227017-81-4

Basic information

• Product Name: tert-butyl (4-(benzylaMino)cyclohexyl)carbaMate
• Synonyms: tert-butyl (4-(benzylaMino)cyclohexyl)carbaMate
• CAS NO: 227017-81-4
• Molecular Formula: C18H28N2O2
• Molecular Weight: 304.42712
• Mol File: 227017-81-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl (4-(benzylaMino)cyclohexyl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (4-(benzylaMino)cyclohexyl)carbaMate(227017-81-4)
• EPA Substance Registry System: tert-butyl (4-(benzylaMino)cyclohexyl)carbaMate(227017-81-4)

Safety Data

• Hazardous Substances Data: 227017-81-4(Hazardous Substances Data)

Usage

General Description

Tert-butyl (4-(benzylamino)cyclohexyl)carbamate is a chemical compound that belongs to the carbamate class of chemicals, which are commonly used in various industries including agriculture, pharmaceuticals, and research. This specific compound consists of a cyclohexyl ring with a benzylamino group attached to it, and a tert-butyl group located on the carbamate functional group. The structure of this chemical provides it with unique properties and potential applications, such as serving as a building block for the synthesis of other organic compounds or as an intermediate in the production of drugs or insecticides. Additionally, the tert-butyl group contributes to the compound's stability and can influence its reactivity and solubility in different solvents. Overall, tert-butyl (4-(benzylamino)cyclohexyl)carbamate is a versatile and potentially valuable chemical with a range of possible uses in various fields.

Upstream product

• 195314-59-1 tert-butyl (4-aminocyclohexyl)carbamate 
• 247570-24-7 tert-butyl N-[(1s,4s)-4-aminocyclohexyl]carbamate 
• 100-52-7 benzaldehyde 
• 177906-48-8 trans-N-Boc-1,4-cyclohexanediamine 

Relevant articles and documents

PYRIDINE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR TREATING DISEASES RELATED TO MCH RECEPTOR

The present invention encompasses novel substituted pyridine compounds of Formula (I), which act as MCH receptor antagonists. These compositions and pharmaceutical compositions thereof are useful in the prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

The present invention encompasses novel substituted pyrimidine compounds of Formula (I): which act as MCH receptor antagonists. These compounds are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson’s disease, epilepsy, and addiction.